A New Method for Identifying Sensory Changes in Painful Chemotherapy-induced Peripheral Neuropathy (CIPN)
NCT03687970 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2021-05-19
Summary
The investigators propose that using the Diode Laser fiber type Selective Stimulator (DLss) in patients with chemotherapy-induced peripheral neuropathy (CIPN) will allow for the assessment of changes in small-fiber pain thresholds, to identify differences between subjects who received chemotherapy and developed painful CIPN, compared to subjects who received similar chemotherapy but did not develop painful CIPN (control group).
Additionally, the investigators would like to investigate whether the response to DLss correlates with pain severity in patients with persistent painful neuropathy.
The ultimate goal of this study is to develop a non-invasive, bedside quantitative test that is specific for painful CIPN. If the investigators' initial hypothesis is confirmed, the next step would be to design a prospective longitudinal study and assess changes in DLss early after initiation of chemotherapy, to determine whether this approach can help identify early predictive parameters of painful CIPN.
Conditions
- Chemotherapy-induced Peripheral Neuropathy
Interventions
- OTHER
-
Brief Pain Inventory
-A self-administered questionnaire used to evaluate the severity of a patient's pain and the impact of this pain on the patient's daily functioning. The patient is asked to rate their worst, least, average, and current pain intensity (4 items which generate the PAIN SEVERITY score), list current treatments and their perceived effectiveness, and rate the degree that pain interferes with general activity, mood, walking ability, normal work, relations with other persons, sleep, and enjoyment of life (7 items which generate the PAIN INTERFERENCE score) on a 10 point scale.
- OTHER
-
Hospital Anxiety and Depression Scale
* 14 item scale with even of the items relating to anxiety and seven relating to depression * Each item on the questionnaire is scored from 0-3 and this means that a patient can score between 0 and 21 for either anxiety or depression
- OTHER
-
Neuropathic Pain Symptom Inventory
-The NPSI questionnaire utilized in this study includes eight parameters (i.e., burning pain, squeezing pain, pressure pain, electric shock pain, stabbing pain, tingling pain, pins and needles pain and allodynia \[pain provoked by light touch\]). Each of the parameters includes recall of the past 24 hours
- PROCEDURE
-
Diode Laser fiber type Selective Stimulator
-Each patient will have an A and C fiber stimulation. Stimulation will be performed on the dorsum of the foot using stimulation previously published parameters to elicit "burning pain," which is from activation of C-fibers and "pinprick" pain from A-fibers
- PROCEDURE
-
Quantitative sensory testing
* Quantitative sensory testing will be performed on the dorsal mid-foot and the ipsilateral shoulder will serve as control area * Cold and warm detection thresholds, cold and heat pain thresholds, mechanical detection thresholds, and wind-up ratio
- PROCEDURE
-
Conditioned pain modulation efficiency
-Immersion of a hand up to the wrist to a thermostat-controlled water bath maintained at 12 degrees Celsius, and the application of a heat stimulus on the contralateral forearm.
- OTHER
-
Spontaneous pain at baseline on 0-10 Numerical Rating Scale (NRS)
-The subjects are asked to rate the intensity of their current pain on a 0-10 scale - 0 denoting "no pain" and 10 denoting "worst imaginable pain".
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
Lasmed LLC
collaborator INDUSTRY -
National Cancer Institute (NCI)
collaborator NIH -
Washington University School of Medicine
lead OTHER
Principal Investigators
-
Simon Haroutounian, Ph.D. · Washington University School of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-17
- Primary Completion
- 2019-09-17
- Completion
- 2019-09-17
Countries
- United States
Study Locations
More Related Trials
-
Sensory Rehabilitation in Chemo Induced Peripheral Neuropathy
NCT06724861 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Photobiomodulation Therapy and Nerve Density for Patients With Diabetic or Chemotherapy-associated Neuropathy
NCT03195868 ·Status: COMPLETED ·Phase: NA
-
A Feasibility Study Investigating Chemotherapy-induced Neuropathy Using Multi-frequency Tactilometry and Patient-reported Outcomes (PRO)
NCT04167319 ·Status: UNKNOWN
-
Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy
NCT07095998 ·Status: RECRUITING ·Phase: NA
-
Internet-delivered Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
NCT05556447 ·Status: WITHDRAWN ·Phase: NA
-
Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study
NCT06162403 ·Status: RECRUITING ·Phase: NA
-
Effects of Sensorimotor Training With Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients
NCT06737926 ·Status: RECRUITING ·Phase: NA
-
Effect of Transcutaneous Electrical Nerve Stimulation on CIPN Symptoms
NCT06499103 ·Status: COMPLETED ·Phase: NA
-
Electrical Stimulation and Chemotherapy Induced Peripheral Neuropathy
NCT02088996 ·Status: UNKNOWN ·Phase: NA
-
Exercise Effect on Chemotherapy-Induced Neuropathic Pain
NCT02991677 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Home-Based Neurofeedback Program in Treating Participants With Chemotherapy-Induced Peripheral Neuropathy
NCT03436680 ·Status: WITHDRAWN ·Phase: NA
-
Identification of Chemotherapy-induced Peripheral Neuropathy
NCT07148336 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
NCT06915168 ·Status: RECRUITING ·Phase: NA
-
Prevention of Chemotherapy-Related Polyneuropathy Via Sensorimotor Exercise Training
NCT02871284 ·Status: COMPLETED ·Phase: NA
-
Characterization and Treatment of Chemotherapy Neuropathy
NCT01557608 ·Status: COMPLETED ·Phase: NA
-
Effects of Telerehabilitation Versus Clinical Rehabilitation on Chemotherapy Induced Peripheral Neuropathy
NCT06696976 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Exercise and Nutrition Interventions During Chemotherapy K07
NCT03858153 ·Status: COMPLETED ·Phase: PHASE2
-
Sensory Rehabilitation in Chemotherapy Induced Peripheral Neuropathy (CIPN)
NCT05382520 ·Status: RECRUITING ·Phase: NA
-
Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy
NCT04959929 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Whole-body Vibration Training to Reduce the Symptoms of Chemotherapy-induced Peripheral Neuropathy
NCT03032718 ·Status: UNKNOWN ·Phase: NA
-
SENSE Study: Remote Symptom Monitoring for Patients With Chemotherapy-induced Peripheral Neuropathy
NCT05330104 ·Status: COMPLETED ·Phase: NA
-
Effects of Transcutaneous Electrical Nerve Stimulation on Chemotherapy-Induced Peripheral Neuropathy
NCT04367480 ·Status: COMPLETED ·Phase: NA
-
Assessing Functional Impairments in Patients With Chemotherapy-Induced Peripheral Neuropathy
NCT07315334 ·Status: NOT_YET_RECRUITING
-
Biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity
NCT03348956 ·Status: COMPLETED ·Phase: NA
-
Exercise and Nutrition Interventions for Platinum Chemotherapy-induced Neuropathy R21
NCT05452902 ·Status: TERMINATED ·Phase: PHASE2